Abstract

OD2-6 CDK9 serves as the potent therapeutic target in tamoxifen-resistant breast cancer cells

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract LB-101: Crosstalk between stromal components and endocrine resistant breast cancer via secreted factors enhances tumor growth and metastasis
Kideok Jin
Cancer Research | VOL. 78
Kideok JinKideok Jin
01 Jul 2018
Data from Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
John W.M Martens ... Johan Bussink
-
John W.M Martens, et. al.John W.M Martens ... Johan Bussink
31 Mar 2023
Data from Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
Marcel Smid ... Anika Nagelkerke
-
Marcel Smid, et. al.Marcel Smid ... Anika Nagelkerke
31 Mar 2023
Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer.
John W.M Martens ... Johan Bussink
Clinical cancer research : an official journal of the American Association for Cancer Research | VOL. 24
John W.M Martens, et. al.John W.M Martens ... Johan Bussink
15 Jul 2018
View more papers

More From: ESMO Open

Paper Title
Journal
Date
Author
Perception of cure in prostate cancer: human-led and artificial intelligence-assisted landscape review and linguistic analysis of literature, social media and policy documents
Ruhee Jain ... Francesco De Solda
ESMO Open | VOL. 9
Ruhee Jain, et. al.Ruhee Jain ... Francesco De Solda
13 May 2024
Patient-reported outcomes with selpercatinib treatment in patients with RET-driven cancers in the phase I/II LIBRETTO-001 trial
Adrienne M Gilligan ... Luis E Raez
ESMO Open | VOL. 9
Adrienne M Gilligan, et. al.Adrienne M Gilligan ... Luis E Raez
01 May 2024
First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study
Natalie Prinzi ... Sandra P D’Angelo
ESMO Open | VOL. 9
Natalie Prinzi, et. al.Natalie Prinzi ... Sandra P D’Angelo
01 May 2024
Treatment and survival of patients diagnosed with high-risk HR+/HER2− breast cancer in the Netherlands: a population-based retrospective cohort study
S.M.E Geurts ... K.B.M.I Keymeulen
ESMO Open | VOL. 9
S.M.E Geurts, et. al.S.M.E Geurts ... K.B.M.I Keymeulen
01 May 2024
View more papers